BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

30 related articles for article (PubMed ID: 31704814)

  • 1. Circulating tumour-derived microvesicles in plasma of gastric cancer patients.
    Baran J; Baj-Krzyworzeka M; Weglarczyk K; Szatanek R; Zembala M; Barbasz J; Czupryna A; Szczepanik A; Zembala M
    Cancer Immunol Immunother; 2010 Jun; 59(6):841-50. PubMed ID: 20043223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of MAGEA6 toggles autophagy to promote pancreatic cancer progression.
    Tsang YH; Wang Y; Kong K; Grzeskowiak C; Zagorodna O; Dogruluk T; Lu H; Villafane N; Bhavana VH; Moreno D; Elsea SH; Liang H; Mills GB; Scott KL
    Elife; 2020 Apr; 9():. PubMed ID: 32270762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The roles of
    Tsang YH; Mills GB
    Autophagy; 2020 Oct; 16(10):1923-1924. PubMed ID: 32809888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting EFNA1 suppresses tumor progression via the cMYC-modulated cell cycle and autophagy in esophageal squamous cell carcinoma.
    Jiang H; Wang S; Liu Y; Zheng C; Chen L; Zheng K; Xu Z; Dai Y; Jin H; Cheng Z; Zou C; Fu L; Liu K; Ma X
    Discov Oncol; 2023 May; 14(1):64. PubMed ID: 37160815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Cancer/Testis Antigens Related to Gastric Cancer Prognosis Based on Co-Expression Network and Integrated Transcriptome Analyses.
    Ansari S; Nikpour P
    Adv Biomed Res; 2023; 12():52. PubMed ID: 37057240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Research progress in effects of MAGE-A family on gastric cancer.
    Jia Q; Xian X; Li Y; Mu J; DU Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Feb; 48(2):260-267. PubMed ID: 36999473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-expression of cancer-testis antigens of MAGE-A6 and MAGE-A11 is associated with tumor aggressiveness in patients with bladder cancer.
    Mohsenzadegan M; Razmi M; Vafaei S; Abolhasani M; Madjd Z; Saeednejad Zanjani L; Sharifi L
    Sci Rep; 2022 Jan; 12(1):599. PubMed ID: 35022469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Key Genes Associated with Progression and Prognosis of Bladder Cancer through Integrated Bioinformatics Analysis.
    Verma S; Shankar E; Lin S; Singh V; Chan ER; Cao S; Fu P; MacLennan GT; Ponsky LE; Gupta S
    Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34885040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-cell receptor-based therapy: an innovative therapeutic approach for solid tumors.
    Tsimberidou AM; Van Morris K; Vo HH; Eck S; Lin YF; Rivas JM; Andersson BS
    J Hematol Oncol; 2021 Jun; 14(1):102. PubMed ID: 34193217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resveratrol acts via melanoma-associated antigen A12 (MAGEA12)/protein kinase B (Akt) signaling to inhibit the proliferation of oral squamous cell carcinoma cells.
    Shang Y; Jiang YL; Ye LJ; Chen LN; Ke Y
    Bioengineered; 2021 Dec; 12(1):2253-2262. PubMed ID: 34085601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Value of Melanoma-Associated Antigen-A (MAGE-A) Gene Expression in Various Human Cancers: A Systematic Review and Meta-analysis of 7428 Patients and 44 Studies.
    Poojary M; Jishnu PV; Kabekkodu SP
    Mol Diagn Ther; 2020 Oct; 24(5):537-555. PubMed ID: 32548799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of ADAM17 expression in patients with gastric cancer who underwent curative gastrectomy.
    Aydin D; Bilici A; Yavuzer D; Kefeli U; Tan A; Ercelep O; Mert A; Yuksel S; Ozcelik M; Isik D; Surmeli H; Odabasi H; Aliustaoglu M
    Clin Transl Oncol; 2015 Aug; 17(8):604-11. PubMed ID: 25786367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Expression of Melanoma-Associated Antigen D2 Both in Surgically Resected and Serum Samples Serves as Clinically Relevant Biomarker of Gastric Cancer Progression.
    Kanda M; Nomoto S; Oya H; Takami H; Shimizu D; Hibino S; Hashimoto R; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
    Ann Surg Oncol; 2016 Feb; 23 Suppl 2():S214-21. PubMed ID: 25743330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathologic features of gastric cancer with synchronous and metachronous colorectal cancer in Korea: are microsatellite instability and p53 overexpression useful markers for predicting colorectal cancer in gastric cancer patients?
    Kim HJ; Kim N; Choi YJ; Yoon H; Shin CM; Park YS; Lee HS; Ahn SH; Park do J; Kim HH; Son IT; Kang SB; Lee DH
    Gastric Cancer; 2016 Jul; 19(3):798-807. PubMed ID: 26445944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of PTH-rP producing gastric cancer with extragastric growth].
    Sakamoto N; Fujisawa T; Kuroda N; Hagino H; Maeda T; Nakahara T; Maeda M; Kohno T; Matsuno Y; Kakudou K
    Nihon Shokakibyo Gakkai Zasshi; 1997 Nov; 94(11):751-6. PubMed ID: 9396330
    [No Abstract]   [Full Text] [Related]  

  • 16. Progress of research in gastric cancer.
    Ali Z; Deng Y; Ma C
    J Nanosci Nanotechnol; 2012 Nov; 12(11):8241-8. PubMed ID: 23421202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue Expression of Melanoma-associated Antigen A6 and Clinical Characteristics of Gastric Cancer.
    Endo M; Kanda M; Sawaki K; Shimizu D; Tanaka C; Kobayashi D; Hattori N; Hayashi M; Yamada S; Koike M; Omae K; Kodera Y
    Anticancer Res; 2019 Nov; 39(11):5903-5910. PubMed ID: 31704814
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.